Reduced Prevalence of Alcoholic Gastritis in Hospitalized Individuals Who Consume Cannabis

被引:10
作者
Adejumo, Adeyinka Charles [1 ,2 ]
Li, Jingjing [3 ]
Akanbi, Olalekan [4 ]
Adejumo, Kelechi Lauretta [5 ]
Bukong, Terence Ndonyi [2 ,3 ]
机构
[1] North Shore Med Ctr, Salem, MA USA
[2] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA
[3] Inst Natl Rech Sci, INRS Inst Armand Frappier, 531 Blvd Prairies, Laval, PQ H7V 1B7, Canada
[4] Univ Kentucky, Coll Med, Div Hosp Med, Lexington, KY USA
[5] Univ Massachusetts, Univ Massachusetts Lowell, Sch Publ Hlth, Lowell, MA USA
关键词
Acute Alcoholic Gastritis; Cannabis; Prevalence; ACID-SECRETION; MUCOSAL DEFENSE; ETHANOL; DELTA-9-TETRAHYDROCANNABINOL; HEMORRHAGES; RECEPTORS;
D O I
10.1111/acer.13930
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background Alcoholic gastritis, a superficial erosive disease of the stomach, is a common manifestation of risky alcohol use. In contrast, cannabis which is frequently co-used with alcohol suppresses gastric acidity and might counteract the deleterious effect of alcohol on the gastric mucosa. However, no clinical study has examined the impact of cannabis use on the development of alcoholic gastritis among risky alcohol users. Methods We analyzed hospital discharge records of adults (age >= 18 years), from 2014 of the Nationwide Inpatient Sample, with a diagnosis of risky alcohol use (n = 316,916). We used a propensity-based matching algorithm to match cannabis users to nonusers on 1:1 ratio (30,713: 30,713). We then measured the adjusted relative risk (aRR) for having alcoholic gastritis using conditional Poisson regression models with generalized estimating equations. Results Our study revealed that among risky alcohol users, cannabis co-users have a lower prevalence of alcoholic gastritis compared to noncannabis users (1,289 [1,169 to 1,421] vs. 1,723 [1,583 to 1,875] per 100,000 hospitalizations for risky alcohol use), resulting in a 25% decreased probability of alcoholic gastritis (aRR: 0.75 [0.66 to 0.85]; p-value <0.0001). Furthermore, dependent cannabis usage resulted in a lower prevalence of alcoholic gastritis when compared to both nondependent cannabis users (0.72 [0.52 to 0.99]) and to noncannabis users (0.56 [0.41 to 0.76]). Conclusions We reveal that risky alcohol drinking combined with cannabis use is associated with reduced prevalence of alcohol-associated gastritis in patients. Given increased cannabis legislation globally, understanding whether and how the specific ingredients in cannabis plant extract can be used in the treatment of alcoholic gastritis is paramount. In this regard, further molecular mechanistic studies are needed to delineate the mechanisms of our novel findings not only for alcoholic gastritis but also for gastritis from other causes.
引用
收藏
页码:270 / 276
页数:7
相关论文
共 43 条
[1]   Effect of Cannabis sativa extract on gastric acid secretion, oxidative stress and gastric mucosal integrity in rats [J].
Abdel-Salam O.M.E. ;
Salama R.A.A. ;
El-Denshary E.-E. ;
Sleem A.A. ;
El-Shamarka M.E.-S. ;
Hassan N.S. .
Comparative Clinical Pathology, 2015, 24 (6) :1417-1434
[2]   Gastric acid inhibitory and gastric protective effects of cannabis and cannabinoids [J].
Abdel-Salam, Omar .
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2016, 9 (05) :401-408
[3]   Gastric antisecretory effects of synthetic cannabinoids after central or peripheral administration in the rat [J].
Adami, M ;
Zamfirova, R ;
Sotirov, E ;
Tashev, R ;
Dobrinova, Y ;
Todorov, S ;
Coruzzi, G .
BRAIN RESEARCH BULLETIN, 2004, 64 (04) :357-361
[4]   Gastric antisecretory role and immunohistochemical localization of cannabinoid receptors in the rat stomach [J].
Adami, M ;
Frati, P ;
Bertini, S ;
Kulkarni-Narla, A ;
Brown, DR ;
de Caro, G ;
Coruzzi, G ;
Soldani, G .
BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (07) :1598-1606
[5]   Cannabis use is associated with reduced prevalence of progressive stages of alcoholic liver disease [J].
Adejumo, Adeyinka C. ;
Ajayi, Tokunbo O. ;
Adegbala, Oluwole M. ;
Adejumo, Kelechi L. ;
Alliu, Samson ;
Akinjero, Akintunde M. ;
Onyeakusi, Nnaemeka E. ;
Ojelabi, Ogooluwa ;
Bukong, Terence N. .
LIVER INTERNATIONAL, 2018, 38 (08) :1475-1486
[6]   Cannabis use is associated with reduced prevalence of non-alcoholic fatty liver disease: A cross-sectional study [J].
Adejumo, Adeyinka Charles ;
Alliu, Samson ;
Ajayi, Tokunbo Opeyemi ;
Adejumo, Kelechi Lauretta ;
Adegbale, Oluwole Muyiwa ;
Onyeakusi, Nnaemeka Egbuna ;
Akinjero, Akintunde Micheal ;
Durojaiye, Modupeoluwa ;
Bukong, Terence Ndonyi .
PLOS ONE, 2017, 12 (04)
[7]  
[Anonymous], 2004, International Statistical Classification of Diseases and Related Health Problems. Tenth revision, volume 2. 4. Rules and guidelines for mortality and morbidity coding
[8]  
4.1.2 underlying cause of death
[9]   Cannabis, a complex plant: different compounds and different effects on individuals [J].
Atakan, Zerrin .
THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2012, 2 (06) :241-254
[10]  
Bujanda L, 2000, AM J GASTROENTEROL, V95, P3374, DOI 10.1111/j.1572-0241.2000.03347.x